IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Abstract
Among the many viruses that are known to infect the human liver, hepatitis B virus (HBV) and hepatitis C virus (HCV) are unique because of their prodigious capacity to cause persistent infection, cirrhosis, and liver cancer. HBV and HCV are noncytopathic viruses and, thus, immunologically mediated events play an important role in the pathogenesis and outcome of these infections. The adaptive immune response mediates virtually all of the liver disease associated with viral hepatitis. However, it is becoming increasingly clear that antigen-nonspecific inflammatory cells exacerbate cytotoxic T lymphocyte (CTL)-induced immunopathology and that platelets enhance the accumulation of CTLs in the liver. Chronic hepatitis is characterized by an inefficient T cell response unable to completely clear HBV or HCV from the liver, which consequently sustains continuous cycles of low-level cell destruction. Over long periods of time, recurrent immune-mediated liver damage contributes to the development of cirrhosis and hepatocellular carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–208 of 208
Hepatitis B viruses and cancerogenesis
Buendia, M. (1998) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(97)86239-7 · Cited by 51
Meyer, K., Basu, A., Przysiecki, C. T., Lagging, M., Bisceglie, A. M. D., Conley, A. J., & Ray, R. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2150-2158.2002 · Cited by 48
Immune exhaustion: driving virus-specific CD8+ T cells to death
Doherty, P. C. (1993) · Trends in Microbiology · doi:10.1016/0966-842x(93)90133-c · Cited by 40
Honda, A., Hatano, M., Kohara, M., Arai, Y., Hartatik, T., Moriyama, T., Imawari, M., Koike, K., Yokosuka, O., Shimotohno, K., et al. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80280-9 · Cited by 37
The Role of Cytotoxic T Lymphocytes in Infectious Disease: History, Criteria, and State of the Art
Oldstone, M. B. A. (1994) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-78530-6_1 · Cited by 35
Prevalence of hepatitis C virus infection in porphyria cutanea tarda
Fargion, S. R., & Fracanzani, A. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00399-4 · Cited by 29
Burioni, R., Mancini, N., Carletti, S., Perotti, M., Grieco, A., Canducci, F., Varaldo, P. E., & Clementi, M. (2004) · Virology · doi:10.1016/j.virol.2004.06.042 · Cited by 27
Dev, A. T., Patel, K., & McHutchison, J. G. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.06.007 · Cited by 19
Cited by
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2014) · Nature Reviews Immunology · doi:10.1038/nri3581 · Cited by 3,297
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Parola, M., & Pinzani, M. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.09.002 · Cited by 1,160
Redefining Chronic Viral Infection
Virgin, H. W., Wherry, E. J., & Ahmed, R. (2009) · Cell · doi:10.1016/j.cell.2009.06.036 · Cited by 1,031
HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
Nassal, M. (2015) · Gut · doi:10.1136/gutjnl-2015-309809 · Cited by 899
Persistent LCMV infection is controlled by blockade of type I interferon signaling
Teijaro, J. R., Ng, C., Lee, A. M., Sullivan, B. M., Sheehan, K. C. F., Welch, M., Schreiber, R. D., Carlos de la Torre, J., & Oldstone, M. B. A. (2013) · Science · doi:10.1126/science.1235214 · Cited by 755
Metadata
- Authors
- Guidotti, L. G., & Chisari, F. V.
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2006-02-01
- Volume
- 1
- Issue
- 1
- Pages
- 23-61
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- OpenAlex
- W2131605289
- Cited by
- 811
- References
- 208
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.